(Q34497277)

2 August 2017

1 reference

title

Pharmacological issues in the treatment of tuberculosis (English)

1 reference

2 August 2017

0 references

1 reference

Peloquin CA

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Annals of the New York Academy of Sciences

2 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 August 2017

volume

953

1 reference

2 August 2017

page(s)

157-164

1 reference

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Using therapeutic drug monitoring to dose the antimycobacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

The effect of hemodialysis on cycloserine, ethionamide, para-aminosalicylate, and clofazimine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Tuberculosis recurrence: multivariate analysis of serum levels of tuberculosis drugs, human immunodeficiency virus status, and other risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

A critical reevaluation of the "therapeutic range" of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Goal-oriented, model-based drug regimens: setting individualized goals for each patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB11374.X

10.1111/J.1749-6632.2001.TB11374.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference